TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE B-

NCT01297400: Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns

Sponsor: Skingenix, Inc. · Phase: PHASE2 · Area: CARDIOLOGY_METABOLIC · Target Enrollment: 60 pts

Competing Trials Overlap

6 Active Trials

Excess Burn Exposure

$1,095,600

Rescue Site Savings

+$730,400

Unlock Full NCT01297400 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT01297400 Rescue Dossier →